Qun Zhao
Hebei Medical University(CN)Hebei University of Economics and Business(CN)Dalian Institute of Chemical Physics(CN)Third Hospital of Hebei Medical University(CN)HBIS (China)(CN)Center for Agricultural Resources Research(CN)Fourth Hospital of Hebei Medical University(CN)Hebei Food Inspection and Research Institute(CN)Kai Biotech (South Korea)(KR)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment, Metastasis and carcinoma case studies, Colorectal Cancer Treatments and Studies, Cancer-related molecular mechanisms research
Most-Cited Works
- → Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial(2023)555 cited
- → Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study(2022)159 cited
- → Sarcopenia: Molecular regulatory network for loss of muscle mass and function(2023)49 cited
- → Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1(2015)48 cited
- → Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial(2022)46 cited